FDA Investigator David A Paterson
David A Paterson has conducted inspections on 140 sites in 3 countries as of 27 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
140
Last Inspection Date:
27 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
France,
United States of America,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with David A Paterson:
Alexandra A Carrico,
Amanda L Baskin,
Amina Bashir,
Andrace L Deyampert,
Andrea D Swingle,
Andrew F Cohen,
Andrew J Barrowcliff,
Anna M Brannen,
Anthony R Petriella,
Art O Czabaniuk,
Ava M Bowman,
Barbara D Bennett,
Bei Y He,
Benjamin J Smith,
Bernard P Heidt,
Beverley A Phillips,
Brandi N Mcgrady,
Brentley S Collins,
Brian M Campbell,
Brian P Hendrickson,
Brian R Yaun,
Burnell M Henry,
Byungja E Marciante,
Calvin K Cook,
Caroline H Le,
Catherine A Spratte,
CDR Kimberly Y Martin,
Charles E Frelix,
Charles I Ann,
Charles L Zhou,
Charles M Spyr,
Cheng H Yen,
Cheryl A Clausen,
Christi L Bellmore,
Constantin Y Philopoulos,
Corrine M Carter,
Crystal M Young Lewis,
Daniel J Brown,
Daniel J Gorski,
Danny Tuntevski,
Dariusz Galezowski,
David J Leray,
Dawn C Olenjack,
Debara R Reese,
Debara Reese,
Denise J Taylor,
Denise L Burosh,
Dennis E Guilfoyle, PhD,
Dennis R Downer,
Dina A Tallman,
Donald C Obenhuber, PhD,
Donna K Speer,
Edwardstine J Reese,
Emest F Bizjak,
Emilie E Kahn,
Emily J Orban,
Enrico Joset Mangahis,
Eric E Joneson,
Eric S Pittman,
Erin M Miller,
Gary Durbiel Goldner,
George G Calafactor,
Gretchen N Kilby,
Hans T Meyers,
Helen B Ricalde,
Ifueko Osemwota,
Jacob G Lutz,
James A Lane,
James N Rench,
Jean Blackston Hill,
Jeffrey A Sommers,
Jeffrey D Meng,
Jeffrey G Baravik,
Jeffrey J Leclair,
Jennifer A Kemp,
Jennifer L Johnson,
Jennifer L Schmidt,
Jennifer R Johnson,
John N Woodall,
Joie A Navarrete,
Joseph A Piechocki,
Joseph R Strelnik,
Joseph S Fanelli,
Joshua M Adams,
Karen M Montgomery (KMM),
Kathryn A Guardiola,
Kathryn G Brown,
Kelley L Clark,
Krista B Jones,
Kristina Nastovski,
L'oreal F Walker,
Larry K Austin,
Lauren E Sexton,
Lauren Iacono Connors, PhD,
Laurimer Kuilan Torres,
Leigh Anne Myers,
Leslie R Morgan,
Linda S Jozefiak,
Lisa M Bellows,
Logan T Williams,
LT Skip A Payne,
Luella J Rossi,
Mancia R Walker,
Mark G Peterson,
Marlon K Turner,
Martin R Vowell,
Megan C Amye,
Megan C Spencer,
Meisha R Sampson,
Meisha Waters,
Melina Lrodriguez Upton,
Mendoza,
Mercy Oyugi,
Michael E Barta,
Michael F Mccoy,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Glendenning,
Miguel Gmanzano Maldonado,
Misty D Harvey,
Montgomery Montgomery, Karen M,
Muna Algharibeh,
Myra K Casey,
Nailing Zhang,
Natalie A Mickelsen, DVM,
Neal D Singletary, PhD,
Neali H Lucas,
Pablo Alcantara,
Patricia A Cochran,
Patricia H Dlugosz,
Patrick B Cummings,
Patsy J Domingo,
Paula A Trost,
Paula P Demichael,
Peng Zhou,
Phuong L Tran,
Qiao Y Bobo,
Rafeeq A Habeeb,
Ralph A Erickson,
Rasha Bamieh,
Raymond T Oji,
Rebecca E Dombrowski,
Rebecca K Olin,
Robert D Tollefsen,
Robert J Ham,
Robert M Barbosa,
Rohn R Robertson,
Rose Ashley,
Rose Xu,
Sandra A Boyd,
Sandra Carpio,
Sara M Onyango,
Sarah B Tanksley,
Sarah M Meng,
Sarah M Napier,
Scott T Ballard,
Simone E Pitts,
Sonya M Lambkin,
Sri Ramakrishnaiah Yellela, PhD,
Susan F Laska, MS,
Susan M Jackson,
Susan P Bruederle,
Suyang Qin,
Tamayo C Barnes,
Tara R Gooen,
Tarsha T Mcclendon,
Terrance P Nguyen,
Theodore N Sietsema,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Travis S Bradley,
Travis V Hull,
Tressa T Lewis,
Vaishali J Patel,
Vera M Anderson,
Vesa Vuniqi,
Wayne E Seifert,
Wenzheng Wendy Zhang,
William D Tingley,
William G Nelson,
William R Brubaker,
Yangmin Ning,
Yazmith Guzman,
Yiwei Li,
Yumi J Hiramine,
Zuleika A Pineiro Vargas
David A Paterson's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2010 | FDA 483 | Applied Laboratories, Inc. - Form 483, 2010-10-18 |
October, 2011 | FDA 483 | Allen Medical, Inc - Form 483, 2011-10-11 |
February, 2010 | FDA 483 | Martin Ekwealor Pharmaceuticals, Inc. - Form 483, 2010-02-17 |
September, 2009 | FDA 483 | KP Pharmaceutical Technology, Inc. - Form 483, 2009-09-22 |
July, 2010 | FDA 483 | Century Pharmaceuticals, Inc. - Form 483, 2010-07-14 |
January, 2010 | FDA 483 | Rush & Hebble Co., Inc. - Form 483, 2010-01-06 |
September, 2010 | FDA 483 | Eli Lilly and Company - Form 483, 2010-09-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more